chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body height
Clinical narrative: Upset stomach; This is a spontaneous report from a contactable consumer(patient). A 77-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1283), via an unspecified route of administration on 25Jan2021 at single dose, left arm for covid-19 immunization. Medical history included hysterectomy from 1993, breast cancer from 28Feb1988 to an unknown date, she had three stents put in on 07Jan2021. Additional Information for Other Conditions reported as they did a mastectomy and had had a prosthesis for 30 years; they took out 18 lymph nodes and still suffers from her right arm being; she had right breast cancer. She shrunk before the vaccine. She had a hysterectomy and breast cancer and could not take any hormones. She guessed that was the reason why she shrunk. She was 5'3" or 5'4" and used to be 5'6". The patient's concomitant medications were not reported. The patient took the shot this morning(25Jan2021). She had an upset stomach on 25Jan2021. She messed her pants. She had three stents put in on the 07Jan2021. This was prior to the vaccine. She ate potato soup a little while before. This was her first dose. Treatment reported as none. The outcome of the event was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Chills; Fever; Aches and pains/throbbing of a headache; Aches and pains/throbbing of a headache; This is a spontaneous report from a contactable consumer. A 70-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number EL9261, via an unspecified route of administration on 24Jan2021 at SINGLE DOSE for covid-19 immunisation. Medical history included COVID-19 flu six months ago. There were no concomitant medications. The patient experienced chills on 25Jan2021 01:00 with outcome of recovering, fever on 25Jan2021 01:00 with outcome of recovering, aches and pains/throbbing of a headache on 25Jan2021 01:00 with outcome of recovering. Her symptoms all started about 1AM, she was woken up to them. Chills: they are better, she has an ice pack on her head for the throbbing of a headache. The action taken was not applicable. She wanted to take a Tylenol. It will probably go away tomorrow she was hoping to get some relief in the mean time.
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report from a contactable consumer. This consumer reported similar events for three patients. This is the second of three reports. A patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231) via unspecified route of administration on 19Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm on 19Jan2021. The outcome of events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021092694 same reporter/drug/event, different patient;US-PFIZER INC-2021092683 same reporter/drug, different patient/event
Sex: U
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This is a spontaneous report from a contactable consumer. This consumer reported similar events for three patients. This is the third of three reports. A patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number unknown) via unspecified route of administration on 19Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced sore arm on an unspecified date. The outcome of events was unknown.   Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021092683 same reporter/drug/event, different patient;US-PFIZER INC-2021092693 same reporter/drug/event, different patient
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Nausea, Pain
Clinical narrative: Tiredness; Dizziness; Nausea; body aches; This is a spontaneous report from a contactable consumer reported for herself. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 12Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced tiredness on Jan2021 with outcome of recovered, dizziness on Jan2021 with outcome of recovered, nausea on Jan2021 with outcome of recovered and body aches on Jan2021 with outcome of unknown. The action taken was not applicable. the reporter stated "she got her first dose on 12Jan and a few days later she had tiredness that went away. She had some issues the past couple of days and wanted to see if it was related. She had dizziness and nausea that went away, she had body aches for a couple of days. Stated that she is getting her second dose on Friday." Information on the lot/batch number has been requested.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dry skin, Lymphadenopathy, Pain, Pruritus, Rash
Clinical narrative: skin was lighter in color; it was really rough; lose; itches; Rash; pain; swollen lymph nodes; This is a spontaneous report from a contactable consumer and contactable other health professional.  A 68-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration at arm left on 11Jan2021 at 11:30 at single dose for COVID-19 immunization. The patient medical history included rheumatoid arthritis, coronary artery disease, both from an unknown date and unknown and COVID-19 from Mar2020 to an unknown date.  There were no concomitant medications.  The patient previously took flu vaccine and pneumococcal vaccine and for both experienced sickness, chills and "couldn't eat". The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration on 22Dec2020 at single dose for COVID-19 immunization and experienced swollen lymph nodes. The patient experienced swollen lymph nodes on 12Jan2021, the rash was first noticed on 13Jan2021 and started on the right under arm (the opposite side she got the shot), there was pain. On 15Jan2021 it moved to the left side. The right side was starting to get better though her skin was lighter in color. The left side was about the same, it was really rough, lose and itches. It looks like elephant skin. Therapeutic measures were taken as result of events and included topic treatment with MINERIN CREAM (therapeutic moisturizer). The patient outcome of swollen lymph nodes was recovered (within 2 days), the outcome of rash and related events was not recovered.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Skin laxity
Clinical narrative: skin was lighter in color; it was really rough; lose; itches; Rash; pain; swollen lymph nodes; This is a spontaneous report from a contactable consumer and contactable other health professional.  A 68-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration at arm left on 11Jan2021 at 11:30 at single dose for COVID-19 immunization. The patient medical history included rheumatoid arthritis, coronary artery disease, both from an unknown date and unknown and COVID-19 from Mar2020 to an unknown date.  There were no concomitant medications.  The patient previously took flu vaccine and pneumococcal vaccine and for both experienced sickness, chills and "couldn't eat". The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration on 22Dec2020 at single dose for COVID-19 immunization and experienced swollen lymph nodes. The patient experienced swollen lymph nodes on 12Jan2021, the rash was first noticed on 13Jan2021 and started on the right under arm (the opposite side she got the shot), there was pain. On 15Jan2021 it moved to the left side. The right side was starting to get better though her skin was lighter in color. The left side was about the same, it was really rough, lose and itches. It looks like elephant skin. Therapeutic measures were taken as result of events and included topic treatment with MINERIN CREAM (therapeutic moisturizer). The patient outcome of swollen lymph nodes was recovered (within 2 days), the outcome of rash and related events was not recovered.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metallic taste in mouth; This is a spontaneous report from a contactable consumer (patient). A 29-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3247, expiry date unknown) via an unspecified route of administration on 28Jan2021 11:45 AM in left arm at single dose for COVID-19 immunization. Medical history included acne and no allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication received within 2 weeks of vaccination included adapalene (DIFFERIN, topical cream) cutaneous for acne. The patient experienced metallic taste in mouth on 28Jan2021 12:00 PM and no treatment was received. The outcome of the event was not recovered. The event was reported as non-serious and no results in death, life threatening, caused or prolonged hospitalization, disabling or incapacitating, congenital anomaly or birth defect involved.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Feeling cold, Gait disturbance, Musculoskeletal stiffness
Clinical narrative: Terrible joint pain and stiffness; Terrible joint pain and stiffness; I could barely walk; This lasted all day it then led into horrible prickly sensation on my back and upper thigh; I then became freezing cold and couldn't warm up; Very tired and thirsty; Very tired and thirsty; This is a spontaneous report from a contactable Other Health Professional reported for herself. A 56-years-old female patient (not pregnant at the time of vaccination) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9265), via an unspecified route of administration in left arm on 28Jan2021 15:15 at single dose for covid-19 immunization.  Medical history included depression. Historical Vaccine included the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. There were no known allergies to medications, food, or other products. Concomitant medication included bupropion hydrochloride (WELLBUTRIN), venlafaxine hydrochloride (EFFEXOR), vitamin d3, calcium, curcuma longa (TURMERIC) and glucose (GLUCOSA). The patient woke up with terrible joint pain and stiffness. She could barely walk. This lasted all day it then led into horrible prickly sensation on her back and upper thigh. She then became freezing cold and couldn't warm up. The patient was also very tired and thirsty. This lasted the entire day and night. All events started from 29Jan2021 07:00 AM. There was no treatment received for the adverse event. The outcome was unknown. The seriousness from reporter was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Thirst
Clinical narrative: Terrible joint pain and stiffness; Terrible joint pain and stiffness; I could barely walk; This lasted all day it then led into horrible prickly sensation on my back and upper thigh; I then became freezing cold and couldn't warm up; Very tired and thirsty; Very tired and thirsty; This is a spontaneous report from a contactable Other Health Professional reported for herself. A 56-years-old female patient (not pregnant at the time of vaccination) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9265), via an unspecified route of administration in left arm on 28Jan2021 15:15 at single dose for covid-19 immunization.  Medical history included depression. Historical Vaccine included the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. There were no known allergies to medications, food, or other products. Concomitant medication included bupropion hydrochloride (WELLBUTRIN), venlafaxine hydrochloride (EFFEXOR), vitamin d3, calcium, curcuma longa (TURMERIC) and glucose (GLUCOSA). The patient woke up with terrible joint pain and stiffness. She could barely walk. This lasted all day it then led into horrible prickly sensation on her back and upper thigh. She then became freezing cold and couldn't warm up. The patient was also very tired and thirsty. This lasted the entire day and night. All events started from 29Jan2021 07:00 AM. There was no treatment received for the adverse event. The outcome was unknown. The seriousness from reporter was non-serious.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Pain in upper left arm; This is a spontaneous report from a contactable consumer (patient).  An 80-year-old female patient received first dose of bnt162b2 (BNT162B2, lot number EL1284) , via an unspecified route of administration on 18Jan2021 14:00 at single dose on left arm for covid-19 immunisation.  There were no medical history and concomitant medications. The patient experienced pain in upper left arm on 24Jan2021 16:00. She received her first injection as initially on 18Jan2021 14:00. It has been about ten days now and she was now feeling pain in her upper left arm. Yesterday and today the pain was intense. She had felt good all week. She has even taken two Tylenol and it has not calmed down the intense pain. Therapeutic measures were taken as a result of pain in upper left arm (pain in extremity). The outcome of the event was not recovered.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Nasopharyngitis, Pyrexia, Weight
Clinical narrative: cold; Fatigue; Chills; Fever; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A 69-year-old female patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL8982) at left arm, via an unspecified route of administration on 21Jan2021 13:30 at single dose for covid-19 immunisation. Medical history was none. Prior vaccinations (within 4 weeks) were none. Family Medical History Relevant to adverse events was none. There were no concomitant medications. The patient experienced chills on 22Jan2021, fever on 22Jan2021, fatigue on 23Jan2021, cold on an unspecified date. The patient received no treatments. The patient had the Pfizer shot last Thursday (21Jan2021) and afterward had chills and fever. Now she was so tired. The events did not require a visit to Emergency Room or Physician Office. The patient's weight was 145-150 lbs. The outcome of events chills and fever was recovered on 23Jan2021; of fatigue was not recovered; of cold was unknown.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose fluctuation, Feeling of body temperature change, Hyperhidrosis, Investigation
Clinical narrative: She said ever since receiving the COVID-19 Vaccine, she has been doing nothing but sweating; She said she will be sweating, and then she gets cold, and then she gets hot; This is a spontaneous report from a contactable consumer (patient).  This 57-year-old female consumer received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) from Lot# EL9261 on Arm, Left Upper at 10:35 on 22Jan2021 at single dose for covid-19 immunization.Medical history included : Type 2 diabetes mellitus (she has been a Type 2 Diabetic for over 10 years ).She said ever since receiving the COVID-19 Vaccine,on 22Jan2021, she has been doing nothing but sweating.She said she will be sweating, and then she gets cold, and then she gets hot .She said she feels like she is overheating. She said she is calling Pfizer to see what she should do. She said she hasn't called her doctor yet, and she is due to take the second COVID-19 Vaccine dose on 09Feb2021.Her sweating, and feeling cold then hot, started on Friday night, 22Jan2021. She said her face was even sweating when she was at work, clarifying she doesn't sweat like that. She said she was even sweating when she was sleeping. She said she will throw back the covers because she feels like she was overheating, and then 5-10 minutes later the heat dissipates, and she has to cover herself back up. This morning she had an episode of sweating, and thought her blood sugar was too high. She said she had just got out of the shower, and she was sweating. She said the ceiling fan was on. She said she was not feverish, but felt hot. She said she immediately checked her blood sugar, and her blood sugar was normal at 113.Her last blood work was in Dec2020. She said she she saw her doctor 3 weeks ago, and her blood work was OK.Outcome of the events was not recovered.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine with aura, Photopsia, Visual impairment
Clinical narrative: migraine aura/migraine that was strong enough that she could not see; flashing lights; blocked vision/migraine was strong enough that she could not see; This is a spontaneous report from a contactable consumer reported for herself. A 87-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284), via an unspecified route of administration on left arm on 18Jan2021 at SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication reported as unspecified (Caller states that she does take a few medications but nothing has changed with those in years, so she does not think anything else is relevant). Historical vaccine include flu shot and does have reactions. Caller stated she received Pfizer COVID shot first dose and within an hour she had migraine without the headache but did have the vision blocked out. It resolved after some time. she wanted to know the ingredient of the vaccine to see if she should take the second dose. Caller states that she had her first Pfizer COVID Shot on 18Jan2021. Caller states that she didn't have any of the ordinary reactions, both the caller and her husband had the shot and neither of them got a sore arm or swelling at the site. Caller states that after they stayed for a half an hour, and when they were driving back to, the caller started to get a migraine aura. Caller states that she has had them before, but not often, and she has not had one for about 10 years. So caller states that her aura started while they were driving, and then the caller's husband dropped the caller off at the grocery store. After being dropped off, caller states that her migraine came on strong. Caller states that her migraine was strong enough that she could not see, she was experiencing flashing lights, and blocked vision. Caller finally turned to another customer to ask if he could see the cucumbers in front of them. Caller states that she waited outside for her husband to get her. Caller states that migraine probably lasted for about 45 minutes. Caller is wondering if this could have been from the shot or not. Caller states that she does have reactions to flu shots sometimes, but not like this. Outcome of the events was recovered on 18Jan2021.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Fatigue, Feeling cold
Clinical narrative: Muscle ache; Chills; Fever; was cold; Joint ache; Tired; Sick; could not sleep all night, she was up half the night; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: F19262), via an unspecified route of administration at her arm on 23Jan2021 at 0.3 mg (as reported) single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that that she and her 94 year old mother got the COVID-19 vaccine at a drive thru, and her mother did great. After the vaccine she had muscle aches, chills, fever, and was cold. She had side effects that lasted 30 hours, starting that night. She was chilling so bad, she would like to know if they think it was safe for her to get the second dose of the vaccine, they said it was worse for the second. She said she could not hardly work she was so sick after the first dose. She stated that she was really cold, and really sick, and all day, she just could not sleep all night, she was up half the night because she was so cold and just feeling sick. She had joint pain, she had it all. She started taking Aleve on Sunday and she started to get better. The night after she got the vaccine she got her heater and was sitting beside it. She felt tired the whole next day. Her symptoms came quicker than that, she took the Aleve the next day.  The outcome of events muscle aches, chills, fever, joint ache was recovered. The outcome of other events was unknown.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Insomnia, Myalgia, Pyrexia
Clinical narrative: Muscle ache; Chills; Fever; was cold; Joint ache; Tired; Sick; could not sleep all night, she was up half the night; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: F19262), via an unspecified route of administration at her arm on 23Jan2021 at 0.3 mg (as reported) single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient reported that that she and her 94 year old mother got the COVID-19 vaccine at a drive thru, and her mother did great. After the vaccine she had muscle aches, chills, fever, and was cold. She had side effects that lasted 30 hours, starting that night. She was chilling so bad, she would like to know if they think it was safe for her to get the second dose of the vaccine, they said it was worse for the second. She said she could not hardly work she was so sick after the first dose. She stated that she was really cold, and really sick, and all day, she just could not sleep all night, she was up half the night because she was so cold and just feeling sick. She had joint pain, she had it all. She started taking Aleve on Sunday and she started to get better. The night after she got the vaccine she got her heater and was sitting beside it. She felt tired the whole next day. Her symptoms came quicker than that, she took the Aleve the next day.  The outcome of events muscle aches, chills, fever, joint ache was recovered. The outcome of other events was unknown.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypoaesthesia, Paraesthesia, Rhinalgia
Clinical narrative: Pin prickly feeling in different areas of her body; Headache; Funny feeling on the top of her head and down her forehead and around her right eye, like a numbing sensation; Stinging feeling in sinus cavity; This is a spontaneous report from contactable consumer (patient)  A 68-years-old female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) from lot#292673 on left deltoid (reported as left shoulder) on 25Jan2021 11:21 at SINGLE DOSE for covid-19 immunisation .  Medical history included diabetes from 11Sep2001 and ongoing , ongoing cardiac pacemaker insertion Put in about 7 years ago , ongoing blood cholesterol increased Diagnosed about 24 years ago , ongoing blood triglycerides increased.  She is allergic to statins. Concomitant medication included alirocumab (PRALUENT) 1 mL at 1ml injection every 14 days for High cholesterol (Injection on side or top of her leg. She has been taking for about 4 year).The patient experienced headache on 25Jan2021 with outcome of recovered , funny feeling on the top of her head and down her forehead and around her right eye, like a numbing sensation on 25Jan2021 with outcome of unknown , stinging feeling in sinus cavity on 25Jan2021 with outcome of recovered , pin prickly feeling in different areas of her body on an unspecified date with outcome of unknown.  Clincial course reported as follows:She got the first dose of the vaccine today and while she was sitting in the observation area, she started getting a headache. It was close to noon and she just blew the headache off since she was a diabetic. She started getting a funny feeling on the top of her head and down her forehead and around her right eye, like a numbing sensation. When the feeling hit her sinus cavity, it was like a stinging. She started drinking water and she had lunch. Within an hour it started getting better and within 3 hours it was a lot better. She has a pin prickly feeling in different areas of her body but did not have the numbness sensation. She tried to report this online. She only had one virtual visit with her doctor. Treatment: declines any, she was drinking plenty of water to try and flush some it out of her system.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: having some bumps that are starting to come up; This is a spontaneous report from a contactable consumer for her husband. A male patient received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Lot Number and Expiration Date unknown) via an unspecified route of administration on an unknown date at single dose for COVID-19 immunisation. The patient's medical history was not reported. The concomitant medications was none. Patient have some bumps that are starting to come up as well on an unknown date. The outcome of event was unknown.  Information on the lot/batch number has been requested.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Dizziness, Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: Light headed and nauseous; Light headed and nauseous; Fever 100.9 degrees and 99.5 degrees; This is a spontaneous report from a contactable other health professional reported for herself. A 34-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: El3247), via an unspecified route of administration at left arm on 29Jan2021 13:00 at single dose for covid-19 immunisation on workplace clinic. Medical history included gluten sensitivity, depression, anxiety, asthma, allergy: tetanus. No pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included sertraline hack 50mg tablet 1.5 tabs once daily within 2 weeks of vaccination. Once the patient got home, she was feeling light headed and nauseous. She checked her temperature and it read 100.9 degrees. She called her work immediately and reported (as the pop up clinic was through her employer). She retook temperature two hours later and was at 99.5 degrees. Event onset time was on 29Jan2021, 1:30 PM. No treatment received. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19. The patient underwent lab tests and procedures which included, SARS-CoV-2 test(nasal, swab): negative.  Outcome was recovering. The case is reported as non serious.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: felt wiped out; Joint pain; Fever as high as 100; arm hurt; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL9261) intramuscular, on 22Jan2021 at single dose in left arm for COVID-19 immunisation. Patient age at vaccination was 75 years. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL3246) received on 02Jan2021 at single dose. Relevant medical history included COVID-19 last Mar2020 and knee replacement on 12Jan2021. The patient received no concomitant medications. The patient reported she had the 2 shots. After both shots, her arm hurt, she felt wiped out, and she had joint pain. After the second shot, she did run a fever as high as 100. She said that she had the second shot on Friday 22Jan2021 and on Saturday she was wiped out. She felt more tired for 3 full days after the first shot and after the second shot she was just wiped out for 1.5 days. The event wiped out had resolved in Jan2021, while outcome of other events was unknown.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Malaise, Nausea
Clinical narrative: Fever; Nausea; Headache; Chills; Ache; she wasn't feeling well; This is a spontaneous report from a contactable consumer (patient's mother).   A 19-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Batch/lot # EL8982) at single dose at right arm on 24Jan2021 15:00 for Covid-19 immunisation, administered at school/student health clinic.  The patient medical history was none. There were no concomitant medications. The patient received the 1st dose of bnt162b2 (BNT162B2, Lot Number: EL1284 and Expiration Date: Apr2021) Intramuscular at single dose in her left arm on 03Jan2021 at around 4:00 PM for Covid-19 immunisation. No additional vaccines administered on same date of BNT162B2. No prior vaccinations (within 4 weeks). On 25Jan2021 the patient experienced fever, nausea, headache, chills, ache, she wasn't feeling well. The patient woke up on 25Jan2021 morning, and was kind of achy. The patient underwent lab tests and procedures which included body temperature: 99.8 on 24Jan2021. Reporter checked her daughter's temperature around on 25Jan2021 an hour before this report, and her daughter has a fever of 99.8, clarifying her daughter's temperature is running about 2 degrees higher than normal. Fever was treated drinking water, and patient uncovered herself to cool her body, and was using cold compresses. The patient was able to eat something, even though, she has some nausea and headache. The patient was feeling well enough to participate in remote learning from home, and she was resting her head on a pillow. The patient had chills on 25Jan2021 morning while in bed. The patient was a healthy, active, who exercises regularly, but and did not go to the gym on 25Jan2021morning because she was not feeling well. No event required a visit to Emergency Room or physician office. No relevant tests performed. The outcome of she wasn't feeling well was unknown, of all other events was not recovered.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Fever; Nausea; Headache; Chills; Ache; she wasn't feeling well; This is a spontaneous report from a contactable consumer (patient's mother).   A 19-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Batch/lot # EL8982) at single dose at right arm on 24Jan2021 15:00 for Covid-19 immunisation, administered at school/student health clinic.  The patient medical history was none. There were no concomitant medications. The patient received the 1st dose of bnt162b2 (BNT162B2, Lot Number: EL1284 and Expiration Date: Apr2021) Intramuscular at single dose in her left arm on 03Jan2021 at around 4:00 PM for Covid-19 immunisation. No additional vaccines administered on same date of BNT162B2. No prior vaccinations (within 4 weeks). On 25Jan2021 the patient experienced fever, nausea, headache, chills, ache, she wasn't feeling well. The patient woke up on 25Jan2021 morning, and was kind of achy. The patient underwent lab tests and procedures which included body temperature: 99.8 on 24Jan2021. Reporter checked her daughter's temperature around on 25Jan2021 an hour before this report, and her daughter has a fever of 99.8, clarifying her daughter's temperature is running about 2 degrees higher than normal. Fever was treated drinking water, and patient uncovered herself to cool her body, and was using cold compresses. The patient was able to eat something, even though, she has some nausea and headache. The patient was feeling well enough to participate in remote learning from home, and she was resting her head on a pillow. The patient had chills on 25Jan2021 morning while in bed. The patient was a healthy, active, who exercises regularly, but and did not go to the gym on 25Jan2021morning because she was not feeling well. No event required a visit to Emergency Room or physician office. No relevant tests performed. The outcome of she wasn't feeling well was unknown, of all other events was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: soreness of the shoulder; This is a spontaneous report from a contactable consumer. This consumer (husband) reported for a female patient (wife) of unknown age that received bnt162b2 (Covid-19 Vaccine), via an unspecified route of administration on 23Jan2021 at 09:00 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. The patient had soreness of the shoulder after she received the vaccine. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Fatigue, Headache, Neck pain
Clinical narrative: Headache Extreme; fatigue; Pain at injection site; armpit and breast (all L) Ncek pain; armpit and breast (all L) Neck pain; armpit and breast (all L) Neck pain; This is a spontaneous report from a non-contactable Other HCP (patient).   A 40-year-old female patient received the 1st dose of bnt162b2 (BNT162B2) at single dose on 19Jan2021 15:00 for an unspecified indication Covid-19 immunisation.  Medical history included irritable bowel syndrome (IBS), asthma, allergies to sulfa. Patient was not pregnant. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications were not reported. No other vaccine was received in four weeks. On 20Jan2021 the patient experienced headache extreme, fatigue, pain at injection site, armpit and breast (all l) neck pain. No treatment received. COVID was not tested post vaccination. The outcome of events was recovering.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Headache Extreme; fatigue; Pain at injection site; armpit and breast (all L) Ncek pain; armpit and breast (all L) Neck pain; armpit and breast (all L) Neck pain; This is a spontaneous report from a non-contactable Other HCP (patient).   A 40-year-old female patient received the 1st dose of bnt162b2 (BNT162B2) at single dose on 19Jan2021 15:00 for an unspecified indication Covid-19 immunisation.  Medical history included irritable bowel syndrome (IBS), asthma, allergies to sulfa. Patient was not pregnant. The patient had not experienced Covid-19 prior vaccination. The patient's concomitant medications were not reported. No other vaccine was received in four weeks. On 20Jan2021 the patient experienced headache extreme, fatigue, pain at injection site, armpit and breast (all l) neck pain. No treatment received. COVID was not tested post vaccination. The outcome of events was recovering.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Musculoskeletal stiffness, Neck pain
Clinical narrative: rash; hives; headache; neck pain; stiffness; sore throat; chills; fever; This is a spontaneous report from a contactable nurse. A 42-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration in Jan2021 at single dose for COVID-19 immunization in hospital. The patient medical history was not reported. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications reported as no. Other vaccine in four weeks was unknown. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly in Dec2020 at single dose for COVID-19 immunization and experienced no adverse events at 42-year-old. It was reported that 21 days later patient received 2nd dose in Jan2021 - within 1-2 hours after injection developed rash (undescribed to reporter) and hives which scattered across both arms and wrists. 3-4 hours after injection developed severe headache and approximately 12 hours later developed neck pain / stiffness- both lasting 3-4 days. Six hours after injection she reported a sore throat. 24 hours after injection temperature rose to 102 with chills, she took paracetamol (TYLENOL) and fever decreased within 8 hours. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as result of the events included paracetamol (TYLENOL). The outcome of the events was recovered in Jan2021.  Information on the lot/batch number has been requested.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, Rash, Urticaria
Clinical narrative: rash; hives; headache; neck pain; stiffness; sore throat; chills; fever; This is a spontaneous report from a contactable nurse. A 42-year-old female patient (not pregnant) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration in Jan2021 at single dose for COVID-19 immunization in hospital. The patient medical history was not reported. Prior to vaccination, patient was not diagnosed with COVID-19. The patient's concomitant medications reported as no. Other vaccine in four weeks was unknown. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly in Dec2020 at single dose for COVID-19 immunization and experienced no adverse events at 42-year-old. It was reported that 21 days later patient received 2nd dose in Jan2021 - within 1-2 hours after injection developed rash (undescribed to reporter) and hives which scattered across both arms and wrists. 3-4 hours after injection developed severe headache and approximately 12 hours later developed neck pain / stiffness- both lasting 3-4 days. Six hours after injection she reported a sore throat. 24 hours after injection temperature rose to 102 with chills, she took paracetamol (TYLENOL) and fever decreased within 8 hours. Since the vaccination, patient had not been tested for COVID-19. Therapeutic measures were taken as result of the events included paracetamol (TYLENOL). The outcome of the events was recovered in Jan2021.  Information on the lot/batch number has been requested.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Pain
Clinical narrative: Swollen lymph node under arm that was injected for 2 days; headache; body ache; tiredness; This is a spontaneous report from a non-contactable pharmacist (patient).   A 24-years-old female patient received the secondo dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) from Lot# El0140 on left arm on 18Jan2021 14:00 at SINGLE DOSE for covid-19 immunisation . First dose details reported as follows: product=COVID 19, brand=Pfizer, lot number=El0140, administration date=28Dec2020, administration time=04:00 PM, vaccine location=Left arm, dose number=1}] Medical history included Pineapple  allergy . Concomitant therapy none.There were no concomitant medications.  The patient started to develop at 7:00 on 19Jan2021 Swollen lymph node under arm that was injected for 2 days, headache, body ache, tiredness that lasted for 3 days.No treatments recevied. Outcome of the events was reported as recovered in Jan2021.  No follow-up attempts are possible; No further information expected .
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Hypertension
Clinical narrative: High heart rate; hypertension; This is a spontaneous report from a contactable pharmacist.  A 49-years-old female no pregnant female patient received ,at hospital, the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) from lot# EL3249 on 12Jan2021 at SINGLE DOSE for covid-19 immunisation .  Medical history included diabetes mellitus, ongoing hypertension,  high cholesterol.  Concomitant medication included metformin (METFORMIN), atorvastatin (ATORVASTATIN), hydrochlorothiazide, losartan potassium (LOSARTAN HCTZ).  On 13Jan2021 the patient experienced high heart rate and .Lab data included heart rate (13Jan2021): high   Outcome of the events was recovering. No Covid prior vaccination, No covid tested post vaccination
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Nausea
Clinical narrative: Mild nausea; Mild fatigue; This is a spontaneous report from a contactable consumer (patient). A 76-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249) via unspecified route of administration at left arm on 14Jan2021 at 08:00 AM at single dose for COVID-19 immunization. Medical history was not provided. The patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included simvastatin (within 2 weeks of vaccination). The patient did not receive any other vaccines within 4 weeks prior to the BNT162B2. The patient experienced mild nausea and mild fatigue 6 hours after injection, at 02:00 PM on 14Jan2021. Duration for one week (6 days 10 hours). The events were reported as non-serious. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive treatment for the adverse events. Outcome of the events was recovered on 21Jan2021.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Sore arm; This is a spontaneous report from a non-contactable consumer (patient). A 50-year-old female patient started to received first dose of BNT162B2 (COVID-19, Pfizer, Solution for injection, lot number: EL3247), via an unspecified route of administration at left arm on 29Jan2021 14:00 at single dose for covid-19 immunisation. Medical history included scleroderma. The patient's concomitant medications were not reported. No other vaccine administration reported within 4 weeks prior to the COVID vaccine. No other medications received within 2 weeks of vaccination. No Allergies to medications, food, or other products were reported. The patient was not pregnant at the time of vaccination. On 29Jan2021 at 19:00 the patient experienced sore arm. No treatment was received for the event. The patient underwent lab tests and procedures which included sars-cov-2 test: COVID-19 virus test was negative prior to vaccination. Since the vaccination, the patient hasn't been tested for COVID-19. The outcome of the event was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain
Clinical narrative: Rash on my upper back; sore/tender armpit on injection arm.; This is a spontaneous report from a contactable other healthcare professional (patient). A 40-year-old female patient received bnt162b2 (Lot: EL0142), via an unspecified route of administration on 07Jan2021 (dose: 1) at 04:00 PM single dose (Left arm) and then on 28Jan2021 (dose: 2, Lot: EL3246) at 03:45 PM single dose for COVID-19 immunization. Medical history included allergies: Sulfa. Concomitant medications included omeprazole, fexofenadine hydrochloride, hydrochlorothiazide, lisinopril (LISINOPRIL HCTZ), iron, fish oil, vitamin D and probiotic. The patient previously took azithromycin (ZITHROMAX) and experienced drug allergy. On 19Jan2021, the patient experienced rash on upper back and sore/tender armpit on injection arm. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Treatment was not received for the adverse events. The outcome of the events was not recovered.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Eye pain, Nausea, Night sweats
Clinical narrative: Chills and night sweats started 2 days later; Chills and night sweats started 2 days later; Pain over left eye; Nausea; No appetite; This is a spontaneous report from a contactable consumer reported for herself. A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, brand=Pfizer, lot number=EL3247) via unspecified route of administration at age of 46 years old on 21Jan2021 05:00 PM at single dose at left arm, for COVID-19 immunization. The patient medical history included patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Other concomitant medications the patient received within 2 weeks of vaccination included sertraline hydrochloride (ZOLOFT 25mg), atorvastatin statin. It was reported patient experienced chills and night sweats started 2 days later. Pain over left eye, nausea, no appetite, can sleep at night. All the adverse events started on 23Jan2021 04:00 PM. It was reported case type non-serious, no results in death, no life threatening, no caused/prolonged hospitalization, no disabling/incapacitating, no congenital anomaly/birth defect. Since the vaccination, the patient had been tested for COVID-19 on 27Jan2021: Nasal Swab (PCR): Negative. There was no treatment received for the adverse event. Outcome of events at the time of last observation was recovering.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Smear test
Clinical narrative: Chills and night sweats started 2 days later; Chills and night sweats started 2 days later; Pain over left eye; Nausea; No appetite; This is a spontaneous report from a contactable consumer reported for herself. A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, brand=Pfizer, lot number=EL3247) via unspecified route of administration at age of 46 years old on 21Jan2021 05:00 PM at single dose at left arm, for COVID-19 immunization. The patient medical history included patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Other concomitant medications the patient received within 2 weeks of vaccination included sertraline hydrochloride (ZOLOFT 25mg), atorvastatin statin. It was reported patient experienced chills and night sweats started 2 days later. Pain over left eye, nausea, no appetite, can sleep at night. All the adverse events started on 23Jan2021 04:00 PM. It was reported case type non-serious, no results in death, no life threatening, no caused/prolonged hospitalization, no disabling/incapacitating, no congenital anomaly/birth defect. Since the vaccination, the patient had been tested for COVID-19 on 27Jan2021: Nasal Swab (PCR): Negative. There was no treatment received for the adverse event. Outcome of events at the time of last observation was recovering.